BACKGROUND: Prostate cancer (PCa) gene expression marker 1 (PCGEM1), a long noncoding RNA, has drawn increasing attention for its important role in PCa. However, the association between genetic variations in the PCGEM1 gene and risk of PCa has not been investigated yet. METHODS: We investigated the effect of two tagging single-nucleotide polymorphism (tSNPs; rs6434568 and rs16834898) in PCGEM1 gene on PCa risk in the Chinese men. Odds ratios (ORs) with 95% confidence intervals (CIs) were used to assess the association. RESULTS: We found a significantly decreased risk of PCa for rs6434568 AC and AC/AA genotype (adjusted OR ¼ 0.76, 95% CI ¼ 0.60-0.97 for AC; adjusted OR ¼ 0.76, 95% CI ¼ 0.61-0.96 for AC/AA), as well as rs16834898 AC and AC/CC genotype (adjusted OR ¼ 0.76, 95% CI ¼ 0.59-0.97 for AC; adjusted OR ¼ 0.79, 95% CI ¼ 0.62-0.99 for AC/CC), compared with the CC and AA genotypes, respectively. When we evaluated these two tSNPs together based on the risk alleles (that is, rs6434568 C and rs16834898 A), we found that the combined genotypes with four risk alleles were associated with an increased risk of PCa compared with those carrying 0-3 risk alleles (1.53, 1.19-1.97), and this increased risk was more pronounced among subjects ofp70 years (1.80, 1.24-2.62), Gleason scorep7 (1.68, 1.28-2.22) and PSA levelX20 (1.64, 1.24-2.18). CONCLUSIONS: Our results indicated that PCGEM1 polymorphisms may contribute to PCa risk in Chinese men. Additional functional analyses are required to detect the detailed mechanism underlying the observed association.
INTRODUCTION
Prostate cancer (PCa) is the most common diagnosed cancer and the second leading cause of cancer-related death in the United States. 1 Although PCa incidence in Asian countries is much lower than in USA, it is increasing substantially in recent years. 2 The most recent estimates for PCa incidence in China was 10/100 000 in 2010, which was much higher than 1.71/100 000 in 1993. 3 PCa has become an emerging health problem in China. Among the established risk factors for PCa, such as age, race, diet and hormone level, genetic variations have been widely accepted as important contributor in driving PCa development. 4, 5 Noncoding RNA (ncRNA), which is previously thought to be 'transcriptional noise' of the genome, has gradually gained attention for its significant functional roles in diverse biological processes, such as regulation of gene expression, regulation of alternative splicing, assembly of cellular structures and so on. 6, 7 As a part of ncRNAs, long noncoding RNAs (lncRNAs), which is defined as ncRNAs with more than 200 nucleotides, 8 also have complex functions. The mechanisms of lncRNA in regulating gene expression are diversified, such as induction of chromatin remodeling, generating endo-siRNAs, altering protein localization and so on. 7, 9 Recently, studies have revealed that lncRNAs are a newly emerging class of oncogenic and tumor-suppressor genes. 10 lncRNAs may exert their functions on carcinogenesis through transcriptional, post-transcriptional, and epigenetic regulations. 10 However, definite roles of lncRNA in cancer development and progression remain largely unknown.
Prostate cancer gene expression marker 1 (PCGEM1), which is a PCa-associated lncRNA, has drawn increasing attention for its important role in PCa initiation and progression. [11] [12] [13] Analysis of PCGEM1 expression has showed it is regulated by androgen, the hormone that has a critical role in PCa, and expression level of PCGEM1 was higher in tumor specimens than in matched normal tissues. 14 Petrovics et al. 12 have observed that PCGEM1 overexpression may promote proliferation of prostate cell through Rb phosphorylation. However, effects of variants in PCGEM1 on PCa risk have not been investigated yet. Given the important roles of PCGEM1 in PCa and the previous observation that single-nucleotide polymorphisms (SNPs) that existed within the sequence of lncRNA were associated with PCa risk, 15 we hypothesized that SNPs in the PCGEM1 gene may contribute to individual PCa susceptibility. As PCGEM1 is only identified to be functional in PCa, rather than other multicancer-related genes, it is rational that PCGEM1 variants may have specific roles in PCa.
In the present study, we selected two tagging SNPs (tSNPs) from the HapMap (http://www.hapmap.org/) database to evaluate 1 the association between genetic variants in PCGEM1 and PCa risk in our hospital-based case-control study in a Chinese population. To the best of our knowledge, it is the first study investigating effects of genetic variants in a candidate lncRNA gene on PCa risk. This study provided further evidence for the important role of lncRNA SNPs in carcinogenisis and a novel perspective of lncRNA's function.
MATERIALS AND METHODS Subjects
We recruited 670 patients with newly diagnosed PCa in The First Affiliated Hospital of Nanjing Medical University and 715 cancer-free controls from the same hospital in an ongoing study starting in September 2003 and lasted until March 2010. The detailed method of recruiting the study subjects has been previously described. 16, 17 All the subjects were genetically unrelated and age matched ( ± 5 years). All cases were histologically confirmed PCa. Only Han Chinese patients were included in this analysis, because genotype frequencies can vary among ethnic groups. The tumor stage was determined using the international tumornode-metastasis staging system for PCa. Based on the tumor-nodemetastasis classification system, the clinical stage was divided into the localized and advanced cancer (localized: T1-2N0M0; advanced: T3-4NxMx or TxN1Mx or TxNxM1). Pathological grade was recorded as the Gleason score. Patients were categorized into two groups according to their serum PSA value: PSAX20 ng ml À 1 and PSAo20 ng ml À 1 , which may predict the prognosis of PCa according to EAU Guidelines on Prostate Cancer in 2008. 18 Control subjects are men who were seeking healthcare for conditions other than cancer, and were excluded if they had an abnormal PSA level or abnormal digital rectal examination.
After informed consent was obtained, all subjects were interviewed faceto-face to collect individual demographic information. Besides, although environmental exposures, such as tobacco or alcohol use were not established risk factors for PCa, some recent studies have showed associations between them.
19,20 Thus, we collected tobacco and alcohol exposure information as well. In this study, the subjects who smoked daily for more than 1 year were defined as ever smokers and the rest as nonsmokers. Pack-years of smoking (cigarettes per day/20) Â (years smoked) were calculated to indicate the cumulative smoking dose. Alcohol drinking was defined as drinking at least three times per week and lasting more than 6 months. Each subject donated 5 ml of venous blood, which was used for genomic DNA extraction. The research protocol was approved by the institutional review board of Nanjing Medical University.
SNP selection, tSNPs identification and genotyping
The PCGEM1 gene, located at chromosome 2q32, consists of three exons and two introns. By using genotype data of Han Chinese in Beijing obtained from the HapMap (HapMap Data Rel 24/Phase II, Nov08, on NCBI B36 assembly, dbSNP b126) and with the pairwise option of the Haploview 4.2 software (Cambridge, MA, USA), we found there were 34 tSNPs altogether in PCGEM1 gene and its flanking regions of 1000-bp upstream. An r 2 of 0.8 was selected as a threshold for the analysis, and performance was defined as the number of SNPs in the evaluated population that had an r 2 40.8 with the tSNPs among the total number of SNPs. Among them, only two tSNPs (that is, rs6434568 and rs16834898) located within the intron region were selected to capture all the common SNPs in PCGEM1. The other 32 SNPs were not included in this study because their minor allele frequencies were too low in Han Chinese (o0.05).
Before genotyping, we conducted DNA quality control. We detected that 27 DNA samples were degradated and dropped them from further genotyping study. Finally, DNA samples of 656 cases and 702 controls were remained. Genotyping was performed with the TaqMan SNP Genotyping Assay using the ABI 7900HT real-time PCR system (Applied Biosystems, Foster City, CA, USA). The tSNPs information, sequences of primers and probes of each SNP are all listed in Supplementary Table S1 . Controls were included in each plate to ensure accuracy of the genotyping. Genotype analysis was done by two persons independently in a blinded fashion. About 10% of the samples were randomly selected for repeated genotyping for confirmation, and the results were 100% concordant. However, there were nine and one samples that failed to generate reliable results for rs6434568 and rs16834898, respectively, and these samples were excluded in further analysis. The call rates of rs6434568 and rs16834898 were 99.3% and 99.9%, respectively.
Statistical analysis
The associations between the PCGEM1 polymorphisms and PCa risk were estimated by calculating the odds ratios (ORs) and their 95% confidence intervals (CIs) from unconditional univariate and multivariate logistic regression analyses. All ORs were adjusted for age, pack-years of smoking and drinking status. w 2 test was used to assess the difference in frequency distribution of each allele and genotype of the PCGEM1 polymorphism between cases and controls. Hardy-Weinberg equilibrium (HWE) of the genotype frequencies of these two polymorphisms among the controls was tested by a goodness-of-fit w 2 test. Further stratified analyses were performed according to age, pack-years of smoking, drinking status and clinical characteristic. The Haploview 4.2 software was used to calculate the D 0 and r 2 value for linkage disequilibrium (LD) between the two polymorphisms. 21 A Po0.05 was considered statistically significant and all statistical tests were two-sided. All the statistical analyses were performed with the SAS 9.1 software (SAS Institute, Cary, NC, USA).
RESULTS

Characteristics of the study population
The frequency distributions of selected characteristics of the remained 656 cases and 702 controls are summarized in Table 1 . There were no statistically significant differences between cases and controls in the distribution of age (P ¼ 0.736). However, there were more ever smokers (58.2%) and ever alcohol users (30.5%) among the cases than among the controls (50.4% and 24.5%, respectively), and these differences were statistically significant (P ¼ 0.004 for tobacco smoking and P ¼ 0.013 for alcohol drinking). Therefore, these variables were further adjusted for in the multivariate logistic regression analysis to assess the main effects of the PCGEM1 polymorphisms on PCa risk. Besides, proportion of Genotype distributions of PCGEM1 tSNPs Allele frequencies and genotype distributions of these polymorphisms in cases and controls are shown in Table 2 . The observed genotype frequencies of these two tSNPs among the control subjects were all in agreement with HWE (w 2 ¼ 1.99, P ¼ 0.158 for rs6434568 and w 2 ¼ 1.28, P ¼ 0.257 for rs16834898). The single loci analysis revealed that the genotype frequencies of neither rs6434568 nor rs16834898 was significantly different between the cases and controls (P ¼ 0.052 for rs6434568 and P ¼ 0.220 for rs16834898). However, multivariate logistic regression analysis indicated that the subjects carrying rs6434568 AC genotype had a significantly lower incidence of PCa than those carrying CC genotype (adjusted OR ¼ 0.76, 95% CI ¼ 0.60-0.97). Similarly, the subjects carrying rs16834898 AC genotype were in significantly decreased risk of PCa (adjusted OR ¼ 0.76, 95% CI ¼ 0.59-0.97) compared with those carrying AA genotype. Moreover, when the wild homozygote CC was taken as the reference, the rs6434568 AC/AA genotypes were associated with a significantly decreased PCa risk (adjusted OR ¼ 0.76, 95% CI ¼ 0.61-0.96). The decreased PCa risk was also observed in rs16834898 AC/CC genotypes (adjusted OR ¼ 0.79, 95% CI ¼ 0.62-0.99) compared with AA genotype. Subsequently, we found that the frequency of rs6434568 A allele was more lower among the cases than that among the controls (P ¼ 0.041). However, there was no significant difference between cases and controls in frequency of rs16834898 C allele (P ¼ 0.209).
Combined analysis of PCGEM1 tSNPs
In the LD analysis, we found that these two PCGEM1 polymorphisms were in moderate LD (D 0 ¼ 0.754, r 2 ¼ 0.528). Considering potential interactions of the two tSNPs on the risk of PCa, we combined these two tSNPs based on the numbers of risk alleles (that is, rs6434568 C and rs16834898 A alleles). As shown in Table 3 , individuals carrying 1-4 risk alleles were not in significantly different PCa risk, when compared with those carrying 0 risk allele. Given that the relatively small sample size of reference group (97 cases and 101 controls) may decrease the statistic power of our analysis, we subsequently dichotomized these combined genotypes into two groups. Results showed that subjects carrying four risk alleles had significantly increased risk of PCa, relative to those with 0-3 risk alleles (adjusted OR ¼ 1.53, 95% CI ¼ 1.19-1.97).
Stratified analysis of PCGEM1 tSNPs The association between the combined effect and PCa risk stratified by age, smoking status and drinking status, considering the imbalance of these two factors across cases and controls ( Table 4) . As a result, the increased risk associated with four risk alleles was more prominent among subgroups of younger individuals (adjusted OR ¼ 1.80, 95% CI ¼ 1.24-2.62).
We further conducted stratified analysis according to some important clinical features, that is, clinical stage, Gleason score and PSA level of PCa patients. It was remarkable that the effect of four risk alleles was more evident in patients with Gleason scorep7 (adjusted OR ¼ 1.68, 95% CI ¼ 1.28-2.22) and PSA levelX20 (adjusted OR ¼ 1.64, 95% CI ¼ 1.24-2.18) ( Table 5 ). These results suggested that the association we observed above may be influenced by some clinical features.
DISCUSSION
In the present study, we selected two tSNPs based on HapMap database, which can capture all the common SNPs in PCGEM1, to assess the impact of lncRNA PCGEM1 variation on PCa risk. As a result, we found in our present hospital-based study that, tSNPs in PCGEM1 may be associated with PCa risk. Individuals with four risk alleles had a significantly higher risk, and this association was more evident in subgroups of Gleason scorep7 and PSA levelX20. These data indicated that genetic variations in PCGEM1 gene may modulate individual susceptibility of PCa. The number represents the number of risk alleles within the combined genotypes, that is, 0-4, which is equal to 0-4 risk alleles; the risk alleles used for the calculation were the rs6434568 C and rs16834898 A alleles. Numbers of subjects included in combined analysis were smaller than that in SNP analysis because subjects genotyped in only one locus were excluded. Several studies have demonstrated that PCGEM1, which was expressed exclusively in human prostate tissue, was dramatically upregulated in PCa tissues compared with normal prostate tissues. [11] [12] [13] Bialkowska-Hobrzanska et al. 22 also found that PCGEM1 was only overexpressed in androgen responsive cell line LNCaP but not in androgen insensitive cell lines PC-3 and DU-145, which validated the previous identification of PCGEM1 as an androgen-regulated prostate-specific gene.
14 Besides, it has been observed that the overexpression of PCGEM1 was more pronounced in PCa patients of African-American region, who have the highest PCa incidence worldwide. 12 Generally, as mentioned by Srikantan et al., 14 elevated expression of PCGEM1 in PCa tissue and relative cells indicated it may have functions in promoting tumor-cell proliferation or survival. Furthermore, there have been some preliminary studies on PCGEM1 functions and the relative mechanism. In another study, Fu et al. 13 found that overexpression of PCGEM1 may attenuate doxorubicin induced expression of p53 and p21
Waf1/Cip1 and inhibits apoptosis of LNCaP cells. Also, Petrovics et al. 12 revealed that the elevated PCGEM1 expression may affect cell proliferation, with a significant increase in Rb phosphorylation. However, to the best of our knowledge, there is no study investigating the functions and relative mechanism of PCGEM1 variation.
A few studies about polymorphisms in lncRNAs have reported significant associations between lncRNA SNPs and risk of disease. 23, 24 Similar with SNPs in protein-coding gene, lncRNA SNPs have also been demonstrated to have functional roles in gene expression, and subsequently modulate disease susceptibility. 25 To date, there has been evidence showing that polymorphisms in lncRNAs were associated with PCa risk. 15 However, up to now, studies investigating the association between the PCGEM1 polymorphisms and PCa susceptibility have not been reported.
To detect the relationship of PCa risk with genetic variants in PCGEM1, which may have potential functions especially in PCa, we conducted this case-control study. Our results showed that individuals carrying AC and AC/AA genotypes of rs6434568 had a lower risk of PCa than those carrying CC genotype. For rs16834898, a decreased PCa risk was also observed in individuals with AC and AC/CC genotypes, compared with those carrying AA genotype. These data suggested an evident modulation of PCa susceptibility by PCGEM1 polymorphisms.
Furthermore, LD analyses between these two tSNPs indicated they were in incomplete linkage. Thus, the potential interactions of these two tSNPs may exist. In the combined analysis, we found The number represents the number of risk alleles within the combined genotypes, from 0 to 4 risk alleles; the risk alleles used for the calculation were the rs6434568 C and rs16834898 A alleles. Numbers of subjects included in combined analysis were smaller than that in SNP analysis because subjects genotyped in only one locus were excluded. The number represents the number of risk alleles within the combined genotypes, from 0 to 4 risk alleles; the risk alleles used for the calculation were the rs6434568 C and rs16834898 A alleles. Numbers of subjects included in combined analysis were smaller than that in SNP analysis because subjects genotyped in only one locus were excluded. 26, 27 which may interfere with PCGEM1. It should be noted that the increased risk were more pronounced in groups of Gleason scorep7, and PSA levelX20, which were different clinical features that would predict different disease prognosis. We attributed these results to the different pathological changes involved in increasing of Gleason score and PSA level. For example, Chin et al. 28 observed that homogeneity of telomerase expression increased with increasing of the Gleason score, while in tumors with Gleason o7, telomerase activation was found to be heterogeneous. Young et al. 29 observed that PSA mRNA could be induced by androgen, which has been identified to be a regulator of PCGEM1 level. Thus, different process in changes of Gleason score and PSA level may have different influence on PCGEM1 and lead to the discrepancy in results of stratified analysis. In addition, relatively small sample size in each stratified group may also interfere with the analysis. Further study with more subjects should be conducted to draw more convinced conclusion.
As both two tSNPs in this study were located in introns of PCGEM1 gene, we could not conduct further studies to detect molecular mechanisms underlying the observed association. To date, the detailed mechanism of relations between intron SNPs and disease development is still unknown. But an increasing number of studies have reported this association [30] [31] [32] [33] and some intron SNPs have been demonstrated to be functional in gene transcription and protein expression. 34, 35 Probably, the association observed in the present study can be explained in similar ways with previous studies 34, 35 and we will focus on this issue in further studies.
The main strength of our study should be addressed that this is the first study to investigate the association between SNPs in the lncRNA PCGEM1 gene and PCa risk, which may provide a new insight into lncRNAs and their function in carcinogenesis. In addition, we applied a rigorous epidemiological design in recruitment of study subjects and match cases and controls by age. Moreover, all observed genotype frequencies of controls in our study were in agreement with HWE. Thus, the selection bias was unlikely to be substantial.
In conclusion, our study showed that tSNPs in PCGEM1 may participate in the modulation of PCa risk in a Chinese population. To confirm our findings, association studies with diverse ethnic populations and further functional studies of the variants are warranted.
